H.U. Group Flags Increase in Stake by U.S. Institutional Investor GMO

HUGroup Holdings ( (JP:4544) ) has issued an update.

H.U. Group Holdings has disclosed a change in its major shareholder following the submission of a large shareholding change report to the Kanto Local Finance Bureau. U.S.-based investment advisory firm Grantham Mayo, Van Otterloo & Co, LLC (GMO) increased its stake in the company, underscoring ongoing overseas institutional interest in the Japanese healthcare group.

GMO’s holding rose from 5,374,300 shares, representing 9.64% of voting rights as of March 21, 2025, to 6,021,600 shares, or 10.80% of voting rights as of February 19, 2026, based on a total of 557,645 voting rights. H.U. Group stated that the change, while elevating GMO’s position as a key shareholder, does not currently entail any specific impact on its business outlook or disclosed operational plans.

The most recent analyst rating on (JP:4544) stock is a Buy with a Yen4370.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

More about HUGroup Holdings

H.U. Group Holdings, Inc. is a Japan-based healthcare company listed on the Prime Market of the Tokyo Stock Exchange under securities code 4544. The group is primarily engaged in clinical testing and related healthcare services, supporting medical institutions and public health infrastructure in Japan and abroad.

Average Trading Volume: 233,020

Technical Sentiment Signal: Buy

Current Market Cap: Yen181.6B

For an in-depth examination of 4544 stock, go to TipRanks’ Overview page.